TCL Archive Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax. November 9, 2001
TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive NCI Drops Two CCOPS, Cincinnati And West Virginia, For Lack Of Patient Entry; 60 Funded Another Year August 24, 1984
TCL Archive FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC. March 30, 2001